. Author manuscript; available in PMC: 2021 May 28.

Published in final edited form as: Clin Transplant. 2020 Dec 12;35(2):e14179. doi: 10.1111/ctr.14179

TABLE 3.

Malignancy in renal transplant patients with ESRD due to anti-glomerular basement membrane disease, n = 4

Malignancy	Time since transplant (years)	Sex	Donor type	Immunosuppression
Squamous cell	15	F	Deceased donor	Cyclosporine
skin	26		Living donor	Mycophenolate
Hepatocellular				Prednisone
Prostate	32	M	Deceased donor	Alemtuzumab
			Living donor	Cyclosporine
				Mycophenolate
				Prednisone
Squamous cell	1	M	Deceased donor	Cyclosporine
skin	2			Mycophenolate
Melanoma				Prednisone
Squamous cell	0.05	M	Deceased donor	Cyclophosphamide
skin				Tacrolimus
				Mycophenolate
				Prednisone